showed a trendP = 0.083
No individual methylated gene was significantly correlated with patients' outcome, although tumors with GATA5 methylation showed a trend towards decreased 5-year survival (64% vs. 82%; P = 0.083).
No individual methylated gene was significantly correlated with patients' outcome, although tumors with GATA5 methylation showed a trend towards decreased 5-year survival (64% vs. 82%; P = 0.083).